Skip to main content
logo
InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.510
-0.070 (-4.43%)
Oct 6, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Novel Therapeutic Products
179.33K
Log In
Novel Therapeutic Products Growth
162.93%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
179.33K
Log In
United States Growth
162.93%
Log In